RedHill Biopharma reported $-1.54M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -6.94M 421K Sep/2025
Cronos Group USD 31.78M 70.78M Sep/2025
RedHill Biopharma USD -1.54M 12M Jun/2024